Brookfield Corporation (BN) Financials

FY2025 annual

Revenue $75.1B -12.7% YoY

Net Income $3.2B +74.6% YoY

Free Cash Flow -$3.8B -5.3% YoY

Operating Cash Flow $11.0B +44.8% YoY

Market Cap $82.7B as of Oct 13, 2026

Price / Sales 1.1x on $75.1B revenue, FY2025

Price / Earnings 25.6x on $3.2B net income, FY2025

Price / Book 0.5x on $166.2B equity, Q4 FY2025

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 13, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period FY2025, ended Dec 31, 2025 Reported Mar 18, 2026 Currency USD FYE December

Newest figures come from the 10-K for FY2025, filed Mar 18, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the BN SEC filings page.

Brookfield Corporation (BN) reported $75.1B in revenue for fiscal year 2025, down 12.7% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 10 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI BN FY2025 2026-10-04

Brookfield’s reported earnings recovered in FY2025, but rising reinvestment kept free cash flow negative despite stronger operating cash generation.

From FY2024 to FY2025, operating cash flow rose from $7.6B to $11.0B, indicating that reported earnings converted into more operating cash. Post-reinvestment cash remained negative at -$3.8B as capital expenditures reached $14.8B, so cash generation was positive before reinvestment but negative afterward.

Revenue fell from $86.0B in FY2024 to $75.1B in FY2025, so the earnings recovery was not driven by top-line growth. Net profit margin nevertheless improved from 2.2% to 4.3%, pointing to changes in costs, mix, or non-operating items rather than simple scale.

From FY2024 to FY2025, assets expanded while equity was nearly unchanged and liabilities rose; this makes liability-funded expansion the more visible financing pattern. At FY2025, total liabilities were $352.8B against a reported debt-to-equity ratio of 0.1x, showing why that ratio alone understates the obligations supporting the asset base.

Financial Health Signals

Financial health score not available

Brookfield Corporation does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Piotroski F-Score Partial

5/6

Brookfield Corporation passes 5 of 6 computable financial strength tests (3 of the nine could not be computed from available data). All 4 profitability signals pass (positive income, cash flow, and earnings quality), all 1 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality Cash-Backed

3.39x

For every $1 of reported earnings, Brookfield Corporation generates $3.39 in operating cash flow ($11.0B OCF vs $3.2B net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Earnings & Revenue

None of these metrics is reported for Q4 2025.

Cash & Balance Sheet

Cash & Debt

$16.2B

YoY+7.9%

QoQ+18.5%

Brookfield Corporation held $16.2B in cash against $14.3B in long-term debt as of Q4 2025.

Free Cash Flow

Not reported for Q4 2025.

Dividends Per Share

Not reported for Q4 2025.

Shares Outstanding

Not reported for Q4 2025.

Margins & Returns

None of these metrics is reported for Q4 2025.

Capital Allocation

None of these metrics is reported for Q4 2025.

BN Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

BN quarterly income statement

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K
Revenue	$75.1B-12.7%	$86.0B-10.3%	$95.9B+3.4%	$92.8B+22.5%	$75.7B+20.7%	$62.8B-7.5%	$67.8B+19.5%	$56.8B+39.2%	$40.8B+67.1%	$24.4B
Interest Expense	$742.0M+2.1%	$727.0M+22.0%	$596.0M-94.4%	$10.7B+40.7%	$7.6B+5.4%	$7.2B-0.2%	$7.2B+48.9%	$4.9B+34.5%	$3.6B+11.6%	$3.2B
Income Tax	$1.1B+15.6%	$982.0M-2.9%	$1.0B-31.2%	$1.5B-36.8%	$2.3B+177.7%	$837.0M+69.1%	$495.0M+299.6%	-$248.0M-140.5%	$613.0M+277.7%	-$345.0M
Net Income	$3.2B+74.6%	$1.9B-63.7%	$5.1B-1.7%	$5.2B-58.1%	$12.4B+1652.2%	$707.0M-86.8%	$5.4B-28.5%	$7.5B+64.5%	$4.6B+36.3%	$3.3B
Diluted Shares (Avg)	2.37B-0.4%	2.38B+49.7%	1.59B-1.2%	1.61B+1.3%	1.59B+5.0%	1.51B+1.5%	1.49B+52.3%	977M0.0%	977M	N/A

Metric	Q4'2510-K	Q2'2510-Q	Q4'2410-K	Q2'2410-Q	Q4'2310-K	Q2'2310-Q	Q4'2210-K	Q2'2210-Q
Revenue	N/A	$18.1B-21.5%	N/A	$23.1B-2.6%	N/A	$23.7B+1.8%	N/A	$23.3B+27.2%
Interest Expense	N/A	$188.0M+3.9%	N/A	$181.0M+17.5%	N/A	$154.0M-93.6%	N/A	$2.4B+31.3%
Income Tax	N/A	$134.0M-55.9%	N/A	$304.0M-25.7%	N/A	$409.0M+190.1%	N/A	$141.0M-74.2%
Net Income	N/A	$1.1B+470.2%	N/A	-$285.0M-118.8%	N/A	$1.5B+2.5%	N/A	$1.5B-39.3%
Diluted Shares (Avg)	N/A	1.57B+2.4%	N/A	1.54B-2.7%	N/A	1.58B-2.4%	N/A	1.62B+4.3%

Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses, SG&A Expenses, Operating Income, EBITDA, EPS (Basic), EPS (Diluted).

BN Balance Sheet

BN quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K
Total Assets	$519.0B+5.8%	$490.4B+0.1%	$490.1B+11.1%	$441.3B+12.9%	$391.0B+13.8%	$343.7B+6.1%	$324.0B+26.4%	$256.3B+33.0%	$192.7B+20.6%	$159.8B
Current Assets	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$9.6B+41.0%	$6.8B
Cash & Equivalents	$16.2B+7.9%	$15.1B+34.1%	$11.2B-22.0%	$14.4B+13.4%	$12.7B+27.8%	$9.9B+46.5%	$6.8B-19.2%	$8.4B+63.3%	$5.1B+19.5%	$4.3B
Inventory	$5.9B+9.3%	$5.4B-23.3%	$7.1B-22.5%	$9.1B+6.4%	$8.6B+35.0%	$6.3B-10.2%	$7.1B+54.1%	$4.6B+27.7%	$3.6B+20.0%	$3.0B
Accounts Receivable	$22.8B+12.3%	$20.3B+0.1%	$20.3B+4.0%	$19.5B+21.1%	$16.1B+13.5%	$14.2B+2.3%	$13.9B+16.4%	$11.9B+40.3%	$8.5B+30.8%	$6.5B
Goodwill	$43.4B+21.3%	$35.7B+2.3%	$34.9B+21.8%	$28.7B+41.7%	$20.2B+37.5%	$14.7B+1.1%	$14.6B+65.1%	$8.8B+65.8%	$5.3B+40.5%	$3.8B
Total Liabilities	$352.8B+8.5%	$325.0B+1.0%	$321.9B+7.5%	$299.4B+16.8%	$256.3B+15.9%	$221.1B+6.7%	$207.1B+30.2%	$159.1B+41.0%	$112.8B+25.2%	$90.1B
Current Liabilities	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$10.3B-3.6%	$10.7B
Non-Current Liabilities	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$63.7B+39.4%	$45.7B
Long-Term Debt	$14.3B+0.5%	$14.2B+17.0%	$12.2B+6.8%	$11.4B+4.7%	$10.9B+19.8%	$9.1B+28.2%	$7.1B+10.5%	$6.4B+13.3%	$5.7B-89.2%	$52.4B
Total Equity	$166.2B+0.5%	$165.4B-1.7%	$168.2B+18.6%	$141.9B+5.3%	$134.7B+9.9%	$122.6B+5.0%	$116.8B+20.3%	$97.2B+21.6%	$79.9B+14.6%	$69.7B

Metric	Q4'2510-K	Q2'2510-Q	Q4'2410-K	Q2'2410-Q	Q4'2310-K	Q2'2310-Q	Q4'2210-K	Q2'2210-Q
Total Assets	$519.0B+5.8%	$506.1B+1.8%	$490.4B+0.1%	$497.3B+7.4%	$490.1B+11.1%	$463.1B+12.4%	$441.3B+12.9%	$411.9B+17.9%
Cash & Equivalents	$16.2B+7.9%	$13.7B+21.8%	$15.1B+34.1%	$11.2B-9.5%	$11.2B-22.0%	$12.4B+1.8%	$14.4B+13.4%	$12.2B+16.7%
Inventory	$5.9B+9.3%	$6.0B-18.5%	$5.4B-23.3%	$7.4B-17.6%	$7.1B-22.5%	$9.0B-3.2%	$9.1B+6.4%	$9.3B+47.5%
Accounts Receivable	$22.8B+12.3%	$22.1B+10.6%	$20.3B+0.1%	$19.9B-3.8%	$20.3B+4.0%	$20.7B+4.0%	$19.5B+21.1%	$19.9B+39.5%
Goodwill	$43.4B+21.3%	$38.7B+12.8%	$35.7B+2.3%	$34.3B+6.0%	$34.9B+21.8%	$32.3B+46.3%	$28.7B+41.7%	$22.1B+47.8%
Total Liabilities	$352.8B+8.5%	$344.4B+4.4%	$325.0B+1.0%	$329.8B+7.2%	$321.9B+7.5%	$307.6B+10.7%	$299.4B+16.8%	$277.9B+24.4%
Long-Term Debt	$14.3B+0.5%	N/A	$14.2B+17.0%	N/A	$12.2B+6.8%	N/A	$11.4B+4.7%	N/A
Total Equity	$166.2B+0.5%	$161.6B-3.5%	$165.4B-1.7%	$167.6B+7.7%	$168.2B+18.6%	$155.6B+16.1%	$141.9B+5.3%	$134.0B+6.4%

Not reported in any period shown, so not listed: Current Assets, Short-Term Investments, Long-Term Investments, Current Liabilities, Non-Current Liabilities, Retained Earnings.

BN Cash Flow Statement

BN quarterly cash flow statement

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K
Operating Cash Flow	$11.0B+44.8%	$7.6B+17.0%	$6.5B-26.1%	$8.8B+11.1%	$7.9B-5.6%	$8.3B+31.8%	$6.3B+22.7%	$5.2B+28.8%	$4.0B+29.9%	$3.1B
Depreciation & Amortization	$10.4B+6.6%	$9.7B+7.3%	$9.1B+18.1%	$7.7B+19.4%	$6.4B+11.2%	$5.8B+18.8%	$4.9B+57.2%	$3.1B+32.3%	$2.3B+16.1%	$2.0B
Capital Expenditures	$14.8B+32.0%	$11.2B+38.5%	$8.1B+11.5%	$7.2B+5.2%	$6.9B+71.5%	$4.0B+31.4%	$3.1B+55.6%	$2.0B+16.1%	$1.7B+14.8%	$1.5B
Free Cash Flow	-$3.8B-5.3%	-$3.6B-124.9%	-$1.6B-205.7%	$1.5B+52.6%	$993.0M-77.1%	$4.3B+32.2%	$3.3B+2.4%	$3.2B+38.1%	$2.3B+43.7%	$1.6B
Investing Cash Flow	-$31.8B-6.1%	-$30.0B-0.7%	-$29.8B+24.9%	-$39.6B-88.4%	-$21.0B-51.7%	-$13.9B+62.2%	-$36.7B-84.9%	-$19.8B-74.1%	-$11.4B-33.2%	-$8.6B
Financing Cash Flow	$21.7B-19.4%	$26.9B+35.0%	$19.9B-38.6%	$32.5B+99.6%	$16.3B+87.0%	$8.7B-69.7%	$28.7B+58.5%	$18.1B+121.6%	$8.2B+17.0%	$7.0B
Dividends Paid	$719.0M+8.4%	$663.0M+10.1%	$602.0M-41.5%	$1.0B-30.8%	$1.5B+71.4%	$867.0M+12.3%	$772.0M+6.3%	$726.0M+6.0%	$685.0M+8.2%	$633.0M

Metric	Q4'2510-K	Q2'2510-Q	Q4'2410-K	Q2'2410-Q	Q4'2310-K	Q2'2310-Q	Q4'2210-K	Q2'2210-Q
Operating Cash Flow	N/A	$2.0B+188.1%	N/A	$698.0M+71.9%	N/A	$406.0M-87.0%	N/A	$3.1B+104.0%
Depreciation & Amortization	N/A	$2.5B+4.1%	N/A	$2.4B+10.0%	N/A	$2.2B+17.4%	N/A	$1.9B+20.1%
Capital Expenditures	N/A	$2.8B+15.6%	N/A	$2.4B+44.5%	N/A	$1.7B-0.5%	N/A	$1.7B+31.9%
Free Cash Flow	N/A	-$745.0M+55.8%	N/A	-$1.7B-35.5%	N/A	-$1.2B-184.8%	N/A	$1.5B+435.8%
Investing Cash Flow	N/A	-$5.9B+29.1%	N/A	-$8.3B-866.2%	N/A	-$862.0M+94.5%	N/A	-$15.5B-1324.2%
Financing Cash Flow	N/A	$5.1B-30.6%	N/A	$7.4B+3332.0%	N/A	-$228.0M-101.7%	N/A	$13.1B+668.3%
Dividends Paid	N/A	$180.0M+8.4%	N/A	$166.0M+9.9%	N/A	$151.0M-41.0%	N/A	$256.0M-66.8%

Not reported in any period shown, so not listed: Stock-Based Compensation, Share Buybacks.

BN Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

BN quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K
Net Margin	4.3%+2.2pp	2.1%-3.2pp	5.3%-0.3pp	5.6%-10.8pp	16.4%+15.2pp	1.1%-6.8pp	7.9%-5.3pp	13.2%+2.0pp	11.2%-2.5pp	13.7%
Return on Equity	1.9%+0.8pp	1.1%-1.9pp	3.0%-0.6pp	3.7%-5.5pp	9.2%+8.6pp	0.6%-4.0pp	4.6%-3.1pp	7.7%+2.0pp	5.7%+0.9pp	4.8%
Return on Assets	0.6%+0.2pp	0.4%-0.7pp	1.0%-0.1pp	1.2%-2.0pp	3.2%+3.0pp	0.2%-1.4pp	1.7%-1.3pp	2.9%+0.6pp	2.4%+0.3pp	2.1%
Current Ratio	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	0.94+0.3x	0.64
Debt-to-Equity	0.090.0x	0.090.0x	0.070.0x	0.080.0x	0.080.0x	0.070.0x	0.060.0x	0.070.0x	0.07-0.7x	0.75
Asset Turnover	0.140.0x	0.180.0x	0.200.0x	0.210.0x	0.190.0x	0.180.0x	0.210.0x	0.220.0x	0.21+0.1x	0.15
FCF Margin	-5.1%-0.9pp	-4.2%-2.5pp	-1.7%-3.3pp	1.6%+0.3pp	1.3%-5.6pp	6.9%+2.1pp	4.8%-0.8pp	5.6%-0.1pp	5.7%-0.9pp	6.6%

Metric	Q4'2510-K	Q2'2510-Q	Q4'2410-K	Q2'2410-Q	Q4'2310-K	Q2'2310-Q	Q4'2210-K	Q2'2210-Q
Net Margin	N/A	5.8%+7.1pp	N/A	-1.2%-7.6pp	N/A	6.4%+0.1pp	N/A	6.3%-6.9pp
Return on Equity	N/A	0.7%+0.8pp	N/A	-0.2%-1.1pp	N/A	1.0%-0.1pp	N/A	1.1%-0.8pp
Return on Assets	N/A	0.2%+0.3pp	N/A	-0.1%-0.4pp	N/A	0.3%0.0pp	N/A	0.4%-0.3pp
Debt-to-Equity	0.090.0x	2.13+0.2x	0.090.0x	1.970.0x	0.070.0x	1.98-0.1x	0.080.0x	2.07+0.3x
Asset Turnover	N/A	0.040.0x	N/A	0.050.0x	N/A	0.050.0x	N/A	0.060.0x
FCF Margin	N/A	-4.1%+3.2pp	N/A	-7.3%-2.1pp	N/A	-5.3%-11.6pp	N/A	6.3%+4.8pp

Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Current Ratio.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
Brookfield Corporation BN	FY2025	$75.1B	$3.2B	4.3%	$82.7B	—
Brookfield Asset Management Ltd. BAM	FY2025	$4.8B	$2.4B	49.8%	$73.3B	19/100
Apollo Global Management, Inc. APO	FY2025	$32.0B	$3.4B	10.6%	$70.1B	14/100
KKR & Co. Inc. KKR	FY2025	$19.5B	$2.4B	12.2%	$81.6B	14/100
Ares Management Corporation ARES	FY2025	$4.8B	$426.1M	9.0%	$26.3B	16/100
Blackrock, Inc. BLK	FY2025	$24.2B	$5.6B	22.9%	$167.6B	56/100

Where Brookfield Corporation Ranks

Frequently Asked Questions

What is Brookfield Corporation's annual revenue?

Brookfield Corporation (BN) reported $75.1B in total revenue for fiscal year 2025. This represents a -12.7% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Brookfield Corporation's revenue growing?

Brookfield Corporation (BN) revenue declined by 12.7% year-over-year, from $86.0B to $75.1B in fiscal year 2025.

Is Brookfield Corporation profitable?

Yes, Brookfield Corporation (BN) reported a net income of $3.2B in fiscal year 2025, with a net profit margin of 4.3%.

How much debt does Brookfield Corporation have?

As of fiscal year 2025, Brookfield Corporation (BN) had $16.2B in cash and equivalents against $14.3B in long-term debt.

What is Brookfield Corporation's net profit margin?

Brookfield Corporation (BN) had a net profit margin of 4.3% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is Brookfield Corporation's return on equity (ROE)?

Brookfield Corporation (BN) has a return on equity of 1.9% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Brookfield Corporation's free cash flow?

Brookfield Corporation (BN) recorded an outflow of $3.8B in free cash flow during fiscal year 2025. This represents a -5.3% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Brookfield Corporation's operating cash flow?

Brookfield Corporation (BN) generated $11.0B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Brookfield Corporation's total assets?

Brookfield Corporation (BN) had $519.0B in total assets as of fiscal year 2025, including both current and long-term assets.

What are Brookfield Corporation's capital expenditures?

Brookfield Corporation (BN) invested $14.8B in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

What is Brookfield Corporation's debt-to-equity ratio?

Brookfield Corporation (BN) had a debt-to-equity ratio of 0.09 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Brookfield Corporation's return on assets (ROA)?

Brookfield Corporation (BN) had a return on assets of 0.6% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Brookfield Corporation's P/E ratio?

Brookfield Corporation (BN) trades at 25.6x earnings, its market capitalization divided by net income of $3.2B net income, FY2025. The market capitalization is $82.7B as of Oct 13, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Brookfield Corporation's price-to-sales ratio?

Brookfield Corporation (BN) trades at 1.1x sales, its market capitalization divided by revenue of $75.1B revenue, FY2025. The market capitalization is $82.7B as of Oct 13, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Brookfield Corporation's Piotroski F-Score?

Brookfield Corporation (BN) has a Piotroski F-Score of 5 out of 6 computable signals; 3 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Brookfield Corporation's earnings high quality?

Brookfield Corporation (BN) has an earnings quality ratio of 3.39x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.